TTY Biopharm Company Limited (4105.TWO)
TWD 72.7
(-0.41%)
TWD 72.7
(-0.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 5.5 Billion | 5.06 Billion | 4.53 Billion | 4.22 Billion | 4.46 Billion |
| Cost of Revenue | 2.28 Billion | 2.04 Billion | 1.76 Billion | 1.61 Billion | 1.6 Billion |
| Gross Profit | 3.22 Billion | 3.02 Billion | 2.76 Billion | 2.6 Billion | 2.85 Billion |
| Operating Expenses | 1.91 Billion | 1.78 Billion | 1.61 Billion | 1.64 Billion | 1.62 Billion |
| Selling, General and Administrative Expenses | 1.53 Billion | 1.43 Billion | 1.32 Billion | 1.38 Billion | 1.32 Billion |
| Research and Development Expenses | 310.43 Million | 353.43 Million | 287.59 Million | 261.59 Million | 298.55 Million |
| Other Expenses | - | 47.43 Million | -183.94 Million | 78.97 Million | - |
| Cost and Expenses | 4.13 Billion | 3.82 Billion | 3.37 Billion | 3.26 Billion | 3.23 Billion |
| Operating Income | 1.37 Billion | 1.42 Billion | 1.11 Billion | 1.21 Billion | 1.22 Billion |
| Interest Expense | 35.36 Million | 23.15 Million | 18.98 Million | 19.41 Million | 14.81 Million |
| Income Tax Expense | 300.86 Million | 305.24 Million | 264.81 Million | 222.84 Million | 294.94 Million |
| Earnings before Tax | 1.28 Billion | 1.4 Billion | 1.08 Billion | 1.2 Billion | 1.24 Billion |
| Net Income | 1.12 Billion | 1.09 Billion | 831.89 Million | 924.17 Million | 900.08 Million |
| Earnings Per Share Basic | 4.54 | 4.40 | 3.35 | 3.72 | 3.62 |
| Earnings Per Share Diluted | 4.53 | 4.40 | 3.34 | 3.71 | 3.61 |
| Weighted Average Shares Outstanding | 248.65 Million | 248.65 Million | 248.65 Million | 248.65 Million | 248.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 249.07 Million | 249 Million | 249.05 Million | 249.06 Million | 248.99 Million |
| Gross Margin | 0.59 | 0.60 | 0.61 | 0.62 | 0.64 |
| EBIT Margin | 0.28 | 0.32 | 0.28 | 0.32 | 0.32 |
| Profit Margin | 0.20 | 0.22 | 0.18 | 0.22 | 0.20 |
| EBITDA | 1.52 Billion | 1.5 Billion | 1.13 Billion | 1.37 Billion | 1.41 Billion |
| Earnings Before Tax Margin | 0.25 | 0.28 | 0.25 | 0.29 | 0.28 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.37 Billion | 1.27 Billion | 5.5 Billion | 1.64 Billion | 1.43 Billion | 1.26 Billion |
| Cost of Revenue | 566.87 Million | 500.74 Million | 2.21 Billion | 769.87 Million | 490.52 Million | 502.09 Million |
| Gross Profit | 807.78 Million | 772.85 Million | 3.28 Billion | 874.89 Million | 942.35 Million | 759.47 Million |
| Operating Expenses | 526.7 Million | 460.44 Million | 1.91 Billion | 582.89 Million | 439.08 Million | 422.59 Million |
| Selling, General and Administrative Expenses | 442.54 Million | 375.56 Million | - | 485.77 Million | 354.18 Million | 359.65 Million |
| Research and Development Expenses | 84.16 Million | 84.88 Million | - | 97.12 Million | 84.89 Million | 62.93 Million |
| Other Expenses | 6.33 Million | -467 Thousand | -142.63 Million | -116.54 Million | -33.89 Million | 12.03 Million |
| Cost and Expenses | 1.09 Billion | 961.19 Million | 4.13 Billion | 1.35 Billion | 929.6 Million | 924.68 Million |
| Operating Income | 360.45 Million | 362.49 Million | 1.44 Billion | 236.07 Million | 515.53 Million | 401.34 Million |
| Interest Expense | 10.12 Million | 7.36 Million | 35.36 Million | 9.11 Million | 9.81 Million | 9.35 Million |
| Income Tax Expense | 77.53 Million | 73.32 Million | 300.86 Million | 46.71 Million | 113.75 Million | 81.59 Million |
| Earnings before Tax | 349.51 Million | 368.05 Million | 1.41 Billion | 227.04 Million | 505.69 Million | 393.38 Million |
| Net Income | 261.71 Million | 280.77 Million | 1.12 Billion | 204.79 Million | 376.33 Million | 308.69 Million |
| Earnings Per Share Basic | 1.05 | 1.13 | - | 0.82 | 1.51 | 1.24 |
| Earnings Per Share Diluted | 1.05 | 1.13 | - | 0.82 | 1.51 | 1.24 |
| Weighted Average Shares Outstanding | 249.24 Million | 248.65 Million | 248.65 Million | 248.65 Million | 249.22 Million | 248.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 249.24 Million | 249.01 Million | 249.07 Million | 249.04 Million | 249.22 Million | 248.94 Million |
| Gross Margin | 0.59 | 0.61 | 0.60 | 0.53 | 0.66 | 0.60 |
| EBIT Margin | 0.29 | 0.32 | - | 0.17 | 0.39 | 0.36 |
| Profit Margin | 0.19 | 0.22 | 0.20 | 0.12 | 0.26 | 0.24 |
| EBITDA | 404.69 Million | 411.54 Million | - | 285.24 Million | 562.65 Million | 455.96 Million |
| Earnings Before Tax Margin | 0.26 | 0.28 | 0.26 | 0.14 | 0.36 | 0.32 |
ADT1
FLYE
AOA
HAYD
8341
5974